Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score

Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) has intracranial activity in EGFR-mutant Non-Small Cell Lung Cancer (NSCLC). The optimal timing of brain radiotherapy (RT) and appropriate patients who need early brain RT remains undetermined. This is a retrospective study of EGF...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Liu, Yongmei, Deng, Lei, Zhou, Xiaojuan, Gong, Youling, Xu, Yong, Zhou, Lin, Wan, Jin, Zou, Bingwen, Wang, Yongsheng, Zhu, Jiang, Ding, Zhenyu, Peng, Feng, Huang, Meijuan, Ren, Li, Lautenschlaeger, Tim, Kong, Feng-Ming (Spring), Lu, You
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5762323/
https://ncbi.nlm.nih.gov/pubmed/29340055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22785
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak